Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Petros Pharmaceuticals In...

    NASDAQ: PTPI · Real-Time Price · USD
    0.03
    -0.00 (-5.96%)
    At close: Jun 06, 2025, 3:59 PM
    0.03
    1.21%
    After-hours: Jun 06, 2025, 03:59 PM EDT

    Petros Pharmaceuticals Statistics

    Share Statistics

    Petros Pharmaceuticals has 31.16M shares outstanding. The number of shares has increased by 0.06% in one year.

    Shares Outstanding

    n/a
    		 31.16M

    Shares Change (YoY)

    n/a
    		 0.06%

    Shares Change (QoQ)

    n/a
    		 -0.01%

    Owned by Institutions (%)

    n/a
    		 3.35%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 238.06K, so 0.76% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 238.06K

    Short % of Shares Out

    n/a
    		 0.76%

    Short % of Float

    n/a
    		 0.77%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -5.52 and the forward PE ratio is null. Petros Pharmaceuticals's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -5.52

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 15.46

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -10.59

    P/FCF Ratio

    n/a
    		 -30.09

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Petros Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.4, with a Debt / Equity ratio of -0.99.

    Current Ratio

    n/a
    		 0.4

    Quick Ratio

    n/a
    		 0.33

    Debt / Equity

    n/a
    		 -0.99

    Debt / EBITDA

    n/a
    		 -0.68

    Debt / FCF

    n/a
    		 -2.81

    Interest Coverage

    n/a
    		 -31.52

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $284,002.39

    Profits Per Employee

    n/a
    		 $-795,488.33

    Employee Count

    n/a
    		 18

    Asset Turnover

    n/a
    		 0.48

    Inventory Turnover

    n/a
    		 0.9

    Taxes

    Income Tax

    n/a
    		 26.78B

    Effective Tax Rate

    n/a
    		 -187046.81%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 1.76, so Petros Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.76

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.72

    200-Day Moving Average

    n/a
    		 5.57

    Relative Strength Index (RSI)

    n/a
    		 27.12

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    In the last 12 months, Petros Pharmaceuticals had revenue of 5.11M and earned -14.32M in profits. Earnings per share was -0.02.

    Revenue

    n/a
    		 5.11M

    Gross Profit

    n/a
    		 3.9M

    Operating Income

    n/a
    		 -17.68M

    Net Income

    n/a
    		 -14.32M

    EBITDA

    n/a
    		 -10.81M

    EBIT

    n/a
    		 -13.76M

    Earnings Per Share (EPS)

    n/a
    		 -0.02
    Full Income Statement

    Balance Sheet

    The company has 3.71M in cash and 7.39M in debt, giving a net cash position of -3.68M.

    Cash & Cash Equivalents

    n/a
    		 3.71M

    Total Debt

    n/a
    		 7.39M

    Net Cash

    n/a
    		 -3.68M

    Retained Earnings

    n/a
    		 -113.21M

    Total Assets

    n/a
    		 17.61M

    Working Capital

    n/a
    		 -12.67M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -2.6M and capital expenditures -24.59K, giving a free cash flow of -2.63M.

    Operating Cash Flow

    n/a
    		 -2.6M

    Capital Expenditures

    n/a
    		 -24.59K

    Free Cash Flow

    n/a
    		 -2.63M

    FCF Per Share

    n/a
    		 -0.33
    Full Cash Flow Statement

    Margins

    Gross margin is 76.28%, with operating and profit margins of -345.84% and -280.1%.

    Gross Margin

    n/a
    		 76.28%

    Operating Margin

    n/a
    		 -345.84%

    Pretax Margin

    n/a
    		 -280.1%

    Profit Margin

    n/a
    		 -280.1%

    EBITDA Margin

    n/a
    		 -211.54%

    EBIT Margin

    n/a
    		 -345.84%

    FCF Margin

    n/a
    		 -51.4%

    Dividends & Yields

    PTPI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PTPI.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 1, 2025. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 May 1, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -12.28

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist